Free Wednesday Night Discussion Group (WNDG)
Upcoming Clinician Discussion Groups
Speaker Announcement Coming Soon
Details for this session are coming soon. The OncoMenopause Consortium's monthly clinician discussion group brings together specialists for evidence-based, expert-led conversations at the intersection of oncology and menopause care. Check back for speaker and topic announcements.
Heart Disease in Cancer Survivors - CardioOncology - Susan Dent, MD, FRCPC
An evidence-based overview of cardio-oncology, focusing on cardiovascular risk, treatment-related cardiotoxicity, and long-term heart health in cancer survivors.
What Clinicians Need to Know When Caring for Survivors of Childhood Cancers - Rebecca L. Eary, DO, MPH & Melissa Erickson, MD
Adult survivors of childhood cancer represent a growing and clinically complex population — one that women's health and oncomenopause providers are increasingly likely to encounter and often feel underprepared to serve. Drs. Eary and Erickson, whose careers are built around bridging the gap between oncology and survivorship primary care, deliver a practical, evidence-informed session on what clinicians need to know when these patients walk through their door.
Menopause Management in Gynecologic Cancer Survivors - Rachel Frankenthal, PA-C
An evidence-based review of menopause management strategies for gynecologic cancer survivors, with practical guidance for individualized, survivorship-centered care.
Non-Hormonal Options for Breast Cancer Survivors - The Data - Milana Dolezal, MD, MSci
Dr. Milana Dolezal delivers a rigorous evidence review of non-hormonal menopause management options for breast cancer survivors — cutting through the noise to examine what the data actually supports for pharmacologic and non-pharmacologic interventions in this population.
Managing Treatment-Induced Menopause in Gynecologic Oncology: Hormonal and Non-Hormonal Approaches - Tiffany Troso-Sandoval, MD
A clinical review of hormonal and non-hormonal approaches to managing treatment-induced menopause in gynecologic oncology, with practical guidance for survivorship care.
Contraception and Breast Cancer Risk - Abigail Liberty, MD, MSPH
For patients with elevated breast cancer risk or a prior diagnosis, contraceptive counseling requires a level of clinical nuance most providers haven't been formally trained to deliver. Dr. Abigail Liberty, whose research sits squarely at the intersection of contraception and breast biology, reviews what the evidence actually shows about hormonal contraceptive risk across patient profiles — and how to translate that evidence into individualized, patient-centered recommendations.
2026 Women's Health Update
A one-day, in-person CME covering menopause management, MHT prescribing, GLP-1 therapies, cardiometabolic risk, and breast cancer screening — led by nationally recognized women's health faculty. 7 AMA PRA Category 1 Credits™. June 19, 2026, Cincinnati, OH.
Testosterone in Breast Cancer Survivors: The Data and an Evidence-Informed Approach - Sarah Glynne, MBBS, MRCOG
A menopause-specialist review of testosterone therapy in breast cancer survivors, with practical guidance for individualized risk assessment and symptom management.
MHT in BRCA Carriers – What it Means for Women at High-Risk of Breast Cancer - Joanne Kotsopoulos, PhD
BRCA carriers face unique and often misunderstood risks when it comes to menopausal hormone therapy — and blanket avoidance can cause real harm. Dr. Joanne Kotsopoulos presents the current evidence on MHT safety in BRCA1 and BRCA2 carriers and provides clinicians with a practical framework for individualized decision-making.
Adjuvant Endocrine Therapy in Breast Cancer: What a Menopause and Breast Cancer Survivorship Specialist Wants You to Know! - Corinne Menn, DO, MSCP
Adjuvant endocrine therapy is one of the most effective tools in breast cancer treatment — and one of the hardest for patients to stay on. Dr. Corinne Menn, menopause specialist and breast cancer survivor, gives clinicians an evidence-based framework for managing side effects and supporting long-term adherence.
Let's DO REAL CASES: Breast Cancer Survivors asking for MHT - Lisa Larkin, MD, FACP, IF, MSCP & Maryam Lustberg, MD, MPH
When breast cancer survivors ask about menopausal hormone therapy, clinicians face complex decisions. This OncoMenopause talk uses real clinical cases to explore evidence-informed approaches to MHT, risk assessment, and shared decision-making.
Managing Bone Health in BC Survivors on AI's - Mike McClung, MD, FACP, FACE
Aromatase inhibitors increase fracture risk in breast cancer survivors. This expert talk explores screening, prevention, and evidence-based strategies to protect long-term bone health after cancer.